A new beta receptor blocking agent LB-46 in angina pectoris. (A double blind clinical trial).
作者信息
Srivastava B N, Jain P C, Vyas G P
出版信息
Indian Heart J. 1972 Jun;24:Suppl 1:203-4.
PMID:4581428
Abstract
摘要
相似文献
1
A new beta receptor blocking agent LB-46 in angina pectoris. (A double blind clinical trial).
Indian Heart J. 1972 Jun;24:Suppl 1:203-4.
2
A double blind study of Visken LB-46, in the treatment of angina pectoris.
Indian Heart J. 1972 Jun;24:Suppl 1:183-91.
3
A double blind drug trial of LB-46 (visken) in angina pectoris.
Indian Heart J. 1972 Jun;24:Suppl 1:192-6.
4
[Beta-blockader, pindolol, in the therapy of angina pectoris; a report on a multicentric controlled study].
Wien Med Wochenschr. 1979 Sep 30;129(17):484-8.
5
LB-46 in angina pectoris. A critique of anti-anginal drug assessment.
Indian Heart J. 1972 Jun;24:Suppl 1:197-20.
6
Prindolol (Visken) and alprenolol (Aptin) in angina pectoris: a comparative clinical study with special reference to ergometer working capacity tests.
Curr Ther Res Clin Exp. 1974 Feb;16(2):101-16.
7
Pindolol (Visken) and angina pectoris: a double blind multicentre trial.
N Z Med J. 1972 Sep;76(484):171-3.
8
Pindolol: a comparison with other antihypertensive drugs and a double-blind placebo trial.吲哚洛尔：与其他抗高血压药物的比较及双盲安慰剂试验。
N Z Med J. 1974 Aug 28;80(522):151-7.
9
[Ergometric study of the association of a beta-blocker and a nitrate derivative].[β受体阻滞剂与硝酸酯衍生物联合应用的测力计研究]
Nouv Presse Med. 1978 Sep 20;7(31):2727-31.
10
Zotero 插件